3-(3-fluorophenyl)-7-methyl-1'-(1H-pyrazol-4-ylmethyl)spiro[5,6-dihydroimidazo[1,2-a]pyrazine-8,4'-piperidine]
C21H25FN6 — CID 155873723
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(3-fluorophenyl)-7-methyl-1'-(1H-pyrazol-4-ylmethyl)spiro[5,6-dihydroimidazo[1,2-a]pyrazine-8,4'-piperidine]
3-(3-fluorophenyl)-7-methyl-1'-(1H-pyrazol-4-ylmethyl)spiro[5,6-dihydroimidazo[1,2-a]pyrazine-8,4'-piperidine] (PubChem CID 155873723) has the molecular formula C21H25FN6 and a molecular weight of 380.47 g/mol. Its IUPAC name is 3-(3-fluorophenyl)-7-methyl-1'-(1H-pyrazol-4-ylmethyl)spiro[5,6-dihydroimidazo[1,2-a]pyrazine-8,4'-piperidine].
Molecular Properties
| Compound Name | 3-(3-fluorophenyl)-7-methyl-1'-(1H-pyrazol-4-ylmethyl)spiro[5,6-dihydroimidazo[1,2-a]pyrazine-8,4'-piperidine] |
|---|---|
| PubChem CID | 155873723 |
| Molecular Formula | C21H25FN6 |
| Molecular Weight | 380.47 g/mol |
| Exact Mass | 380.21 |
| IUPAC Name | 3-(3-fluorophenyl)-7-methyl-1'-(1H-pyrazol-4-ylmethyl)spiro[5,6-dihydroimidazo[1,2-a]pyrazine-8,4'-piperidine] |
| SMILES | CN1CCn2c(-c3cccc(F)c3)cnc2C12CCN(Cc1cn[nH]c1)CC2 |
| InChI | InChI=1S/C21H25FN6/c1-26-9-10-28-19(17-3-2-4-18(22)11-17)14-23-20(28)21(26)5-7-27(8-6-21)15-16-12-24-25-13-16/h2-4,11-14H,5-10,15H2,1H3,(H,24,25) |
| InChIKey | HRFBJBPTOIJHTH-UHFFFAOYSA-N |
| XLogP | 2.85 |
| TPSA | 52.98 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 380.47 |
| LogP ≤ 5 | 2.85 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155873723 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.